A low nicotine concentration augments vesicle motion and exocytosis triggered by K+ depolarisation of chromaffin cells

European Journal of Pharmacology

Volumn 598, Issue 1-3, 2008, Pages 81-86

  de Diego, Antonio M G ^a,b   Tapia, Laura ^a,b   Álvarez, Rocío M ^a,d   Mosquera, Marta ^a,b   Cortés, Lorena ^a,b   López, Inmaculada ^e   Gutiérrez, Luis M ^e   Gandía, Luis ^a,b   García, Antonio G ^a,b,c  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d UNIVERSIDAD DE VALPARAÍSO   (Chile)

^e MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Chromaffin cell; Exocytosis; Nicotine; Nicotinic receptors

Indexed keywords

ADRENALIN; CALCIUM; CATECHOLAMINE; NICOTINE; POTASSIUM;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR RISK; CATECHOLAMINE RELEASE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CHROMAFFIN CELL; CONTROLLED STUDY; COW; EXOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; SECRETORY VESICLE; SMOKING; STRESS;

EID: 54149087258     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.09.003     Document Type: Article

References (34)

1. Arnáiz-Cot J.J., de Diego A.M., Hernández-Guijo J.M., Gandía L., and García A.G. A two-step model for acetylcholine control of exocytosis via nicotinic receptors. Biochem. Biophys. Res. Commun. 365 (2008) 413-419
2. Becherer U., Moser T., Stuhmer W., and Oheim M. Calcium regulates exocytosis at the level of single vesicles. Nat. Neurosci. 6 (2003) 846-853
3. Benowitz N.L. Pharmacology of nicotine: addiction and therapeutics. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 597-613
4. Benowitz N.L., Porchet H., Sheiner L., and Jacob III P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther. 44 (1988) 23-28
5. Bevan J.A., and Su C. Uptake of nicotine by the sympathetic nerve terminals in the blood vessel. J. Pharmacol. Exp. Ther. 182 (1972) 419-426
6. 3H-norepinephrine and on endogenous norepinephrine levels in the rat brain. Eur. J. Pharmacol. 2 (1967) 234-235
7. Borges R., Sala F., and García A.G. Continuous monitoring of catecholamine release from perfused cat adrenals. J. Neurosci. Methods 16 (1986) 289-300
8. Campos-Caro A., Smillie F.I., Dominguez del Toro E., Rovira J.C., Vicente-Agulló F., Chapuli J., Juiz J.M., Sala S., Sala F., Ballesta J.J., and Criado M. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J. Neurochem. 68 (1997) 488-497
9. 3H]-nicotine and [3H]-noradrenaline by cultured chromaffin cells. Br. J. Pharmacol. 81 (1984) 119-123
10. Ceña V., Nicolás G.P., Sánchez-García P., Kirpekar S.M., and García A.G. Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release. Neuroscience 10 (1983) 1455-1462
11. Criado M., Alamo L., and Navarro A. Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells. Neurochem. Res. 17 (1992) 281-287
12. Cuchillo-Ibáñez I., Olivares R., Aldea M., Villarroya M., Arroyo G., Fuentealba J., García A.G., and Albillos A. Acetylcholine and potassium elicit different patterns of exocytosis in chromaffin cells when the intracellular calcium handling is disturbed. Pflugers Arch. 444 (2002) 133-142
13. de Pascual R., and Garcia A.G. Ouabain augments and maintains the catecholamine release responses evoked by repetitive pulses of potassium, caffeine or histamine in perifused bovine chromaffin cells. Eur. J. Pharmacol. 568 (2007) 99-105
14. Fenwick E.M., Marty A., and Neher E. Sodium and calcium channels in bovine chromaffin cells. J. Physiol. 331 (1982) 599-635
15. Gandia L., Casado L.F., Lopez M.G., and Garcia A.G. Separation of two pathways for calcium entry into chromaffin cells. Br. J. Pharmacol. 103 (1991) 1073-1078
16. Green D.J., and Perlman R.L. On-line measurement of catecholamine secretion. Anal. Biochem. 110 (1981) 270-276
17. Heinemann C., von Ruden L., Chow R.H., and Neher E. A two-step model of secretion control in neuroendocrine cells. Pflugers Arch. 424 (1993) 105-112
18. Johns L.M., Levitan E.S., Shelden E.A., Holz R.W., and Axelrod D. Restriction of secretory granule motion near the plasma membrane of chromaffin cells. J. Cell Biol. 153 (2001) 177-190
19. Kawagoe K.T., Zimmerman J.B., and Wightman R.M. Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods 48 (1993) 225-240
20. Kirpekar S.M., Garcia A.G., and Prat J.C. Action of nicotine on sympathetic nerve terminals. J. Pharmacol. Exp. Ther. 213 (1980) 133-138
21. Lindmar R., Loffelholz K., and Muscholl E. A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Br. J. Pharmacol. Chemother. 32 (1968) 280-294
22. Livett B.G. Adrenal medullary chromaffin cells in vitro. Physiol. Rev. 64 (1984) 1103-1161
23. Mehta M.C., Jain A.C., Mehta A., and Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J. Cardiovasc. Pharmacol. Ther. 2 (1997) 291-298
24. Miranda-Ferreira R., de Pascual R., de Diego A.M., Caricati-Neto A., Gandia L., Jurkiewicz A., and Garcia A.G. Single-vesicle catecholamine release has greater quantal content and faster kinetics in chromaffin cells from hypertensive, as compared with normotensive, rats. J. Pharmacol. Exp. Ther. 324 (2008) 685-693
25. Moro M.A., López M.G., Gandía L., Michelena P., and García A.G. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal. Biochem. 185 (1990) 243-248
26. 2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron 20 (1998) 389-399
27. Ñeco P., Giner D., Viniegra S., Borges R., Villarroel A., and Gutiérrez L.M. New roles of myosin II during vesicle transport and fusion in chromaffin cells. J. Biol. Chem. 279 (2004) 27450-27457
28. Orozco C., Garcia-de-Diego A.M., Arias E., Hernandez-Guijo J.M., Garcia A.G., Villarroya M., and Lopez M.G. Depolarization preconditioning produces cytoprotection against veratridine-induced chromaffin cell death. Eur. J. Pharmacol. 553 (2006) 28-38
29. Richardson J.A., and Woods E.F. Release of norepinephrine from the isolated heart. Proc. Soc. Exp. Biol. Med. 100 (1959) 149-151
30. Sharma G., and Vijayaraghavan S. Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 38 (2003) 929-939
31. Srivastava E.D., Russell M.A., Feyerabend C., Masterson J.G., and Rhodes J. Sensitivity and tolerance to nicotine in smokers and nonsmokers. Psychopharmacology (Berl.) 105 (1991) 63-68
32. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's: The Pharmacological Basis of Therapeutics (1996), McGraw-Hill, Madrid 217-236
33. von Ruden L., and Neher E. A Ca-dependent early step in the release of catecholamines from adrenal chromaffin cells. Science 262 (1993) 1061-1065
34. Zhou Z., and Neher E. Calcium permeability of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells. Pflugers Arch. 425 (1993) 511-517